Department of Pharmacology, Louisiana State University Health Sciences Center, School of Medicine, 1501 Kings Highway, P.O. Box 33932, Shreveport, LA 71130, USA.
Mol Neurobiol. 2013 Jun;47(3):988-99. doi: 10.1007/s12035-013-8397-7. Epub 2013 Jan 16.
Delivery of exogenous glial cell line-derived neurotrophic factor (GDNF) increases locomotor activity in rodent models of aging and Parkinson's disease in conjunction with increased dopamine (DA) tissue content in substantia nigra (SN). Striatal GDNF infusion also increases expression of GDNF's cognate receptor, GFRα1, and tyrosine hydroxylase (TH) ser31 phosphorylation in the SN of aged rats long after elevated GDNF is no longer detectable. In aging, expression of soluble GFRα1 in the SN decreases in association with decreased TH expression, TH ser31 phosphorylation, DA tissue content, and locomotor activity. Thus, we hypothesized that, in aged rats, replenishing soluble GFRα1 in SN could reverse these deficits and increase locomotor activity. We determined that the quantity of soluble GFRα1 in young adult rat SN is ~3.6 ng. To replenish age-related loss, which is ~30 %, we infused 1 ng soluble GFRα1 bilaterally into SN of aged male rats and observed increased locomotor activity compared to vehicle-infused rats up to 4 days following infusion, with maximal effects on day 3. Five days after infusion, however, neither locomotor activity nor nigrostriatal neurochemical measures were significantly different between groups. In a separate cohort of male rats, nigral, but not striatal, DA, TH, and TH ser31 phosphorylation were increased 3 days following unilateral infusion of 1 ng soluble GFRα1into SN. Therefore, in aged male rats, the transient increase in locomotor activity induced by replenishing age-related loss of soluble GFRα1is temporally matched with increased nigral dopaminergic function. Thus, expression of soluble GFRα1 in SN may be a key component in locomotor activity regulation through its influence over TH regulation and DA biosynthesis.
外源性胶质细胞系衍生神经营养因子(GDNF)的传递增加了衰老和帕金森病啮齿动物模型的运动活性,同时增加了黑质(SN)中的多巴胺(DA)组织含量。纹状体 GDNF 输注还增加了老年大鼠 SN 中 GDNF 配体受体 GFRα1 和酪氨酸羟化酶(TH)ser31 磷酸化的表达,即使升高的 GDNF 不再可检测到很长时间后也是如此。在衰老过程中,SN 中可溶性 GFRα1 的表达与 TH 表达降低、TH ser31 磷酸化、DA 组织含量和运动活性降低有关。因此,我们假设,在老年大鼠中,补充 SN 中的可溶性 GFRα1 可以逆转这些缺陷并增加运动活性。我们确定,年轻成年大鼠 SN 中可溶性 GFRα1 的数量约为 3.6ng。为了补充与年龄相关的损失(约 30%),我们将 1ng 可溶性 GFRα1 双侧注入老年雄性大鼠的 SN,并观察到与对照组相比,运动活性在注射后 4 天内增加,在第 3 天达到最大效果。然而,在注射后 5 天,两组之间的运动活性或黑质纹状体神经化学测量均无显著差异。在另一组雄性大鼠中,单侧注射 1ng 可溶性 GFRα1 进入 SN 后 3 天,黑质但不是纹状体中的 DA、TH 和 TH ser31 磷酸化增加。因此,在老年雄性大鼠中,补充与年龄相关的可溶性 GFRα1 损失引起的运动活性短暂增加与黑质多巴胺能功能的增加时间匹配。因此,SN 中可溶性 GFRα1 的表达可能是通过其对 TH 调节和 DA 生物合成的影响调节运动活性的关键组成部分。